Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Free-Cash-Flow-To-The-Firm" stands at 47.27 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Sumitomo Dainippon Pharma Co Ltd's second quarter result of 25.73 Billion JPY for the item "Free Cash Flow To The Firm" represents an increase of 731.15 percent compared to it's first quarter result.
Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of 25.73 Billion JPY for the item "Free Cash Flow To The Firm" represents a decrease of -34.15 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of 47.27 Billion JPY for the item "Free Cash Flow To The Firm" represents a decrease of -22.01 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 102.42 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 102.42 Billion Japanese Yens.
The 3 year change is -32.02 Billion Japanese Yens.
The 5 year change is 9.48 Billion Japanese Yens.
The 10 year change is 13.83 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Free Cash Flow To The Firm | 905,699,262,464.00 |
![]() | Johnson & Johnson - Free Cash Flow To The Firm | 486,508,953,600.00 |
![]() | AbbVie Inc - Free Cash Flow To The Firm | 399,570,305,024.00 |
![]() | Roche Holding AG - Free Cash Flow To The Firm | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Free Cash Flow To The Firm | 280,205,508,085.11 |